I-MAB |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.805 USD | +0.28% |
|
0.00% | -5.26% |
| Apr. 18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
| Apr. 15 | I-Mab Announces Chief Medical Officer Changes | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 1.850 | 2.370 | 3.180 |
| Spread/Res. | -2.70% | -24.05% | -43.40% |
| Spread/Supp. | +0.56% | +47.54% | +50.00% |
| Support | 1.790 | 1.220 | 1.200 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- IMAB Stock
- Charts I-Mab
